![]() |
|
|
Vol. 20, Issue 7, 1970-1980, April 1, 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




,
*Graduate Program in Biochemistry, Cell, and Developmental Biology, and
Department of Cell Biology, and
Department of Dermatology, Emory University, Atlanta, GA 30322; and
The Center for Cardiovascular Sciences, Albany Medical College, Albany, NY 12208
Submitted July 18, 2008;
Revised January 13, 2009;
Accepted February 3, 2009
Monitoring Editor: M. Bishr Omary
p120-catenin is a cytoplasmic binding partner of cadherins and functions as a set point for cadherin expression by preventing cadherin endocytosis, and degradation. p120 is known to regulate cell motility and invasiveness by inhibiting RhoA activity. However, the relationship between these functions of p120 is not understood. Here, we provide evidence that p120 functions as part of a plasma membrane retention mechanism for VE-cadherin by preventing the recruitment of VE-cadherin into membrane domains enriched in components of the endocytic machinery, including clathrin and the adaptor complex AP-2. The mechanism by which p120 regulates VE-cadherin entry into endocytic compartments is dependent on p120's interaction with the cadherin juxtamembrane domain, but occurs independently of p120's prevention of Rho GTPase activity. These findings clarify the mechanism for p120's function in stabilizing VE-cadherin at the plasma membrane and demonstrate a novel role for p120 in modulating the availability of cadherins for entry into a clathrin-dependent endocytic pathway.
Address correspondence to: Andrew P. Kowalczyk (akowalc{at}emory.edu)
Abbreviations used: AP-2, adaptor complex 2; DN DynII, dominant negative dynamin II; IL-2R, interleukin-2 receptor; JMD, juxtamembrane domain; MEC, human microvascular endothelial cell; p120, p120 catenin.
This article has been cited by other articles:
![]() |
Z. Wang, R. Ginnan, I. F. Abdullaev, M. Trebak, P. A. Vincent, and H. A. Singer Calcium/Calmodulin-dependent Protein Kinase II Delta 6 (CaMKII{delta}6) and RhoA Involvement in Thrombin-induced Endothelial Barrier Dysfunction J. Biol. Chem., July 9, 2010; 285(28): 21303 - 21312. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Oas, K. Xiao, S. Summers, K. B. Wittich, C. M. Chiasson, W. D. Martin, H. E. Grossniklaus, P. A. Vincent, A. B. Reynolds, and A. P. Kowalczyk p120-Catenin Is Required for Mouse Vascular Development Circ. Res., March 19, 2010; 106(5): 941 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Grinnell, B. Casserly, and E. O. Harrington Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium Am J Physiol Lung Cell Mol Physiol, March 1, 2010; 298(3): L361 - L370. [Abstract] [Full Text] [PDF] |
||||